OConnell Daniel Joseph - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 21, 2025, OConnell Daniel Joseph's relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Director,Officer (Chief Executive Officer), and currently has 667,488 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABOS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

OConnell Daniel Joseph - Insider Non-Derivative Transactions of ABOS Common Stock

OConnell Daniel Joseph - Insider Non-Derivative Transactions at ABOS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 22, 2025	Sell -- (Common Stock)	12619	1.59	667488
Jan 8, 2025	Acquisition -- (Common Stock)	225400	0	680107
Jan 4, 2025	Sell -- (Common Stock)	47778	1.84	454707
Jan 20, 2024	Sell -- (Common Stock)	15200	3.47	502485
Jan 3, 2024	Acquisition -- (Common Stock)	401000	0	517685
Jan 18, 2023	Acquisition -- (Common Stock)	114000	0	116685